| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/15/2008 | US7399849 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 07/15/2008 | US7399845 For modulating gene expression pathways, including those relying on mechanisms of action such as RNaseH, RNAi and dsRNA enzymes, as well as other antisense mechanisms based on target degradation or target occupancy; of therapeutic, diagnostics, and research applications; nuclease resistance |
| 07/15/2008 | US7399821 Alkylated poly(allylamine) polymers and methods of use |
| 07/15/2008 | US7399790 Virucidal compositions |
| 07/15/2008 | US7399789 Bone targeting compounds for delivering agents to bone for interaction therewith |
| 07/15/2008 | US7399788 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
| 07/15/2008 | US7399787 Methods of treating cancer with HDAC inhibitors |
| 07/15/2008 | US7399786 Derivatives of amino acids for treatment of obesity and related disorders |
| 07/15/2008 | US7399785 N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor |
| 07/15/2008 | US7399784 Tocopherol and tocotrienol anti-obesity medicaments |
| 07/15/2008 | US7399783 Topically applying flavonoids |
| 07/15/2008 | US7399782 Disease involving mucus transport |
| 07/15/2008 | US7399781 N-substituted benzothiophenesulfonamide derivatives |
| 07/15/2008 | US7399780 pyridin-2-yl-1H-indole or pyrimidin-4-yl-1H-indole derivatives; enzyme inhibitor of glycogen synthase kinase-3; treating dementia, Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis, corticobasal degeneration, Down syndrome, Huntington's Disease |
| 07/15/2008 | US7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists |
| 07/15/2008 | US7399778 by targeting beta and gamma secretase enzyme decreases production of amyloid precursor protein; 5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide; Alzheimer's Disease, Down's Syndrome, cognitive decline |
| 07/15/2008 | US7399777 Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals |
| 07/15/2008 | US7399776 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
| 07/15/2008 | US7399775 β-amyloid protein production/secretion inhibitor |
| 07/15/2008 | US7399774 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 07/15/2008 | US7399773 Intermediates in the synthesis of atorvastatin calcium (Lipitor (reg)), 5-(4-fluorophenyl)-2-isopropyl-1-(4-(morpholinocarbonylmethylcarbonyl)-2-hydroxybutyl)-4-phenyl-3-(N-phenylcarbamoyl)-1H-pyrrole for example |
| 07/15/2008 | US7399772 Substituted benzimidazole dosage forms and method of using same |
| 07/15/2008 | US7399771 Piperidine derivatives as CCR5 inhibitors |
| 07/15/2008 | US7399770 N-(hydroxy)-2-(4'-chlorobiphenyl-4-sulfonyl)-4-hydroxy-1,2,3,4-tetrahydrobenzo[4,5]thieno[3,2-c]pyridine-1-carboxamide; collagenase inhibitor; antiinflammatory, angiogenesis agent, wound healing agent; arthritis, multiple sclerosis, osteoarthrosis, atherosclerosis, restenosis, myocardial infarction |
| 07/15/2008 | US7399769 3-(5-methyl-3-phenyl-isoxazol-4-yl)-imidazo[1,5-a]pyridine-6-carboxylic acid methyl ester; gamma aminobutyric acid GABA A alpha 5 receptor inverse agonist; relatively free of activity at GABA A alpha 1, alpha 2 and alpha 3 receptor binding; cognition activator, Alzheimer's disease; |
| 07/15/2008 | US7399768 1-methyl-3 beta -hydroxymethyl-6-methoxy-1,2,3,4,4a alpha ,5,10, 10a beta -octahydrobenzo[q]quinoline; decrease on the intraocular pressure; glaucoma and myopia; excellent tolerability, and a long duration of action |
| 07/15/2008 | US7399766 Soluble amide & ester pyrazinoylguanidine sodium channel blockers |
| 07/15/2008 | US7399765 Substituted diazabicycloalkane derivatives |
| 07/15/2008 | US7399764 N-ethyl-N'-{(3R)-1-[4-(3-phenylthieno[3,4-b]pyrazin-2-yl)benzyl]pyrrolidin-3-yl}urea; inhibit activity of a serine, threonine protein kinase; cancer |
| 07/15/2008 | US7399763 and highly specific HIV replication inhibitor; ethyl 2-benzyl-8-hydroxy-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2- alpha ]pyrazine-7-carboxylate; aquired immune deficiency syndrome (AIDS) |
| 07/15/2008 | US7399762 Opioid receptor agonist compounds and their use in treatment of pain |
| 07/15/2008 | US7399761 Phthalazine derivatives with angiogenesis inhibiting activity |
| 07/15/2008 | US7399760 1-(4-Methylsulfanyl-phenyl)-6-phenyl-pyrimidin-2,4-(1H)-dione;cyclooxygenase and prostaglandin inhibitor; tumor necrosis factor and interleukins 1, 6, 8, 12 antagonist; |
| 07/15/2008 | US7399759 1, 3-benzothiazinone derivatives and use thereof |
| 07/15/2008 | US7399758 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| 07/15/2008 | US7399757 biphenyl-diazene oxide carboxylate compounds; pesticide; controlling undesirable pests by applying to plant foliage |
| 07/15/2008 | US7399756 Organo-phosphorous compounds for activating gamma/delta T cells |
| 07/15/2008 | US7399755 Prophylaxis and therapy of coronary artery disease |
| 07/15/2008 | US7399754 N2-quinoline or isoquinoline substituted purine derivatives |
| 07/15/2008 | US7399753 Transgenic cell comprising recombinant conditionally replicative adenovirus coding photoreactive protein which when combined with photosensitizer induces cytolysis/apoptosis in cells; tissue directed therapy |
| 07/15/2008 | US7399752 Detection, calibration binding of ligand to nucleic acids |
| 07/15/2008 | US7399751 Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells |
| 07/15/2008 | US7399748 Intravenous administration of a alpha -halogen- acryloyl distamycin derivative for therapy of tumors |
| 07/15/2008 | US7399747 Peptides carrying substances across the blood brain barrier |
| 07/15/2008 | US7399745 polypeptides, fragments and/or variants, used for treatment of metabolic disorders, such as diabetes and obesity; hypoglycemic agents |
| 07/15/2008 | US7399741 Notch |
| 07/15/2008 | US7399606 Methods for identifying IκB Kinase (IKK) inhibitors |
| 07/15/2008 | US7399604 Methods and products related to evaluating the quality of a polysaccharide |
| 07/15/2008 | US7399492 Composition and method for issue repair and regeneration |
| 07/15/2008 | US7399485 Rapidly Disintegrable solid preparation |
| 07/15/2008 | US7399481 Methods for treating, maintaining, or improving fur or hair pigmentation of domestic carnivores using a composition comprising free tyrosine |
| 07/15/2008 | US7399479 Water; an oil phase, which contains hydrophobic oil and optionally dissolved lipophilic materials, and an emulsifier mixture of an ethoxylated (hydrogenated) castor oil and an emulsifier with a given NRU50 value; storage stability, clarity; eye compatibility |
| 07/15/2008 | US7399478 Cosmetic, pharmaceutical and dermatological products |
| 07/15/2008 | US7399473 Virus coat protein/receptor chimeras and method of use |
| 07/15/2008 | US7399472 Vaccines |
| 07/15/2008 | US7399464 Polypeptides of the IFNα-7 gene |
| 07/15/2008 | US7399462 Dapsone protectants that reduce the risk of skin damage; sunscreen |
| 07/15/2008 | US7399460 Cancer diagnosis; antitumor agents, radiotherapy |
| 07/15/2008 | CA2480583C Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
| 07/15/2008 | CA2479924C Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization |
| 07/15/2008 | CA2478980C Pulmonary delivery for levodopa |
| 07/15/2008 | CA2465640C Process for forming amorphous atorvastatin |
| 07/15/2008 | CA2441836C New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kitfor preparation of the liver cancer-treating composition |
| 07/15/2008 | CA2425913C Erythromycin derivative having novel crystal structures and processes for their production |
| 07/15/2008 | CA2425560C Anticholinergics, processes for preparing them and their use as pharmaceutical compositions |
| 07/15/2008 | CA2421120C Quinolinone derivatives as tyrosine kinase inhibitors |
| 07/15/2008 | CA2416369C Use of polysulphated cyclodextrins for treating osteoarthritis |
| 07/15/2008 | CA2407606C Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents |
| 07/15/2008 | CA2397942C Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation |
| 07/15/2008 | CA2395530C Calcium formate for use as a phosphorus binder and a dietary supplement |
| 07/15/2008 | CA2392096C Polymorphic form of atorvastatin calcium |
| 07/15/2008 | CA2373296C Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
| 07/15/2008 | CA2371940C Pregelatinized starch in a controlled release formulation |
| 07/15/2008 | CA2362515C Utilization of material containing docosapentaenoic acid |
| 07/15/2008 | CA2362271C Essential fatty acids in the prevention of cardiovascular events |
| 07/15/2008 | CA2361602C Firm hold hair mousse |
| 07/15/2008 | CA2361237C Lyophilisates having improved reconstitutibility |
| 07/15/2008 | CA2355175C Soluble compositions of triphenylethylene antiestrogens |
| 07/15/2008 | CA2349711C A method of producing drug particles |
| 07/15/2008 | CA2348693C Natural formulation for the treatment and prevention of depression, containing st john's wort and derivatives of dihydro- and tetrahydrofolic acid |
| 07/15/2008 | CA2339250C Synthesis of acyclic nucleoside derivatives |
| 07/15/2008 | CA2334411C Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma |
| 07/15/2008 | CA2330669C Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives |
| 07/15/2008 | CA2315258C Neuroprotective agents |
| 07/15/2008 | CA2298522C 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy |
| 07/15/2008 | CA2289086C Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells |
| 07/15/2008 | CA2283327C Cationic lipid compositions targeting angiogenic endothelial cells |
| 07/15/2008 | CA2282184C Stable, pulverulent lycopene formulations, comprising lycopene having a degree of crystallinity of greater than 20% |
| 07/15/2008 | CA2279620C 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4) |
| 07/15/2008 | CA2250861C Cyclic adhesion inhibitors |
| 07/15/2008 | CA2250630C Novel lantibiotic related to actagardine, and processes for the preparation and use thereof |
| 07/15/2008 | CA2247848C Nitric oxide donors capable of reducing toxicity from drugs |
| 07/15/2008 | CA2245637C Antipsoriatic nail polish |
| 07/15/2008 | CA2236641C Preparation of fagopyritols and uses therefor |
| 07/15/2008 | CA2231545C Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 07/15/2008 | CA2213612C Composition for controlling parasites |
| 07/15/2008 | CA2208605C 14.alpha.,17.alpha.-c2-bridged 19-nor-progesterone derivatives |
| 07/15/2008 | CA2207103C Methods to identify hemochromatosis |
| 07/15/2008 | CA2205557C Monofunctional and/or polyfunctional polylysine conjugates |
| 07/15/2008 | CA2202503C Modified polyunsaturated fatty acids |